Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:24Prosopagnosia
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genes.
Brain : a journal of neurology·2025
Same author
Genome wide association study of clinical duration and age at onset of sporadic CJD.
PloS one·2024
Gerstmann-Sträussler-Scheinker disease.
1Department of Molecular Pathology and Neuropathology, Medical University Lodz, Lodz, Poland. ppliber@csk.am.lodz.pl
Advances in Experimental Medicine and Biology
|March 14, 2012
Summary
Gerstmann-Sträussler-Scheinker syndrome is a rare, inherited prion disease. This review details its clinical, neuropathological, and genetic aspects, focusing on PRNP gene mutations.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Gerstmann-Sträussler-Scheinker (GSS) syndrome is an autosomal dominant, hereditary prion disease.
- It represents the first identified human transmissible spongiform encephalopathy (TSE) linked to prion protein gene (PRNP) mutations.
Purpose of the Study:
- To present comprehensive clinical, neuropathological, and molecular data on GSS.
- To review known mutations in the PRNP gene associated with GSS.
Main Methods:
- Review of clinical case studies and neuropathological findings.
- Molecular analysis of PRNP gene mutations.
- Literature review of GSS cases and associated genetic data.
Main Results:
Conclusions:
- GSS is a genetically determined prion disease with diverse PRNP mutations.
- Further research is needed to identify unknown mutations in GSS families.
- Understanding these mutations is crucial for diagnosis and potential therapeutic strategies.